Compare Ginkgo Bioworks Holdings Inc (DNA) vs Enbridge Inc (ENB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Enbridge Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Enbridge Inc trades at $51.75 (market cap $112.62B). The key difference: Enbridge Inc is far larger — about 222.7× Ginkgo Bioworks Holdings Inc's market cap, and Enbridge Inc pays a 5.34% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | ENB | |
|---|---|---|
Market Cap | $505.73M | $112.62B |
Sector | Health | Energy |
52-Week High | $16.14 | $58.04 |
52-Week Low | $5.48 | $45.23 |
Enterprise Value | $607.68M | $196.53B |
Dividend Yield | — | 5.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →
